EU Financial Regulatory Q&A Database
Official Q&As published by EBA, ESMA, EIOPA and the ESA Joint Committee. Non-binding but treated as authoritative guidance by national competent authorities across the EU.
2,125 Q&As matching current filters · page 41 of 43
Back-to-Back in regulatory threshold
Regulation (EU) No 575/2013 (CRR) · Art. 325a
Submitted 2023-03-12
Recognition of minority interest of a subsidiary subject to own funds requirements on individual level
Regulation (EU) No 575/2013 (CRR) · Art. 84, 85, 87
Submitted 2023-02-09
SRT test in securitisations
Regulation (EU) No 575/2013 (CRR) · Art. 244 and 245
Submitted 2022-12-30
Exemption of exposures to public sector entities
Regulation (EU) No 575/2013 (CRR) · Art. 429a
Submitted 2022-10-28
Treatment of multi-seller securitisations in CRR
Regulation (EU) No 575/2013 (CRR) · Art. 244 and 268
Submitted 2022-06-22
Scope of Prudential consolidation
Regulation (EU) No 575/2013 (CRR) · Art. 22
Submitted 2022-05-17
EAD value for CVA calculation
Regulation (EU) No 575/2013 (CRR) · Art. 384
Submitted 2022-03-23
Calculation of a Prudent Value in combination with CET1-Deduction according to article 89 and 90 CRR
Regulation (EU) No 575/2013 (CRR) · Art. 105
Submitted 2022-03-11
Exposure class for fair value changes of the hedged items in portfolio hedge of interest rate risk
Regulation (EU) No 575/2013 (CRR) · Art. 112
Submitted 2022-02-11
Calculation of the CET1 deduction for non-performing exposures (NPEs)
Regulation (EU) No 575/2013 (CRR) · Art. 36 (1) m, 47a-c and 469a CRR
Submitted 2022-02-02
Application of Article 22 CRR for (mixed) financial holding companies in light of the approval procedure under Article 21a CRD
Regulation (EU) No 575/2013 (CRR) · Art. 22
Submitted 2021-11-19
Scope of prudential consolidation
Regulation (EU) No 575/2013 (CRR) · Art. 22
Submitted 2021-11-11
Definition of long/short derivative positions
Regulation (EU) No 575/2013 (CRR) · Art. 273a
Submitted 2021-10-14
Relevance of a person association's purpose for SME supporting factor application
Regulation (EU) No 575/2013 (CRR) · Art. 501
Submitted 2021-09-20
Interdependent assets and liabilities – NSFR treatment for centralised regulated savings
Regulation (EU) No 575/2013 (CRR) · Art. 428f
Submitted 2021-07-12
Definition of parent undertaking for the purposes of CRR
Regulation (EU) No 575/2013 (CRR) · Art. 4
Submitted 2021-07-09
Deduction of software assets from Common Equity Tier 1 capital (hereinafter CET1) for investment firms of Class 2 and Class 3
Regulation (EU) No 575/2013 (CRR) · Art. 36
Submitted 2021-07-07
Specific Wrong-Way risk (SWWR) – Identification and treatment with respect to transactions referencing a basket of names or an index
Regulation (EU) No 575/2013 (CRR) · Art. 291
Submitted 2021-06-22
Exemption from and alternatives to deduction from Common Equity Tier 1 items
Regulation (EU) No 575/2013 (CRR) · Art. 46, 48
Submitted 2021-05-28
treatment of uncommitted facilities / limits
Regulation (EU) No 575/2013 (CRR) · Art. 166
Submitted 2021-05-02
Point in time when facility or limit is considered to be a commitment
Regulation (EU) No 575/2013 (CRR) · Art. 166
Submitted 2021-05-02
Treatment of committed facilities with unadvised limits
Regulation (EU) No 575/2013 (CRR) · Art. 166
Submitted 2021-05-02
Definition of subsidiary for the purposes of the CRR
Regulation (EU) No 575/2013 (CRR) · Art. 4
Submitted 2020-10-22
Determination of a default risk-free discount factor
Regulation (EU) No 575/2013 (CRR) · Art. 132c
Submitted 2020-09-24
Institution responsible for compliance with the requirements on a consolidated basis in a horizontally consolidated group
Regulation (EU) No 575/2013 (CRR) · Art. 18
Submitted 2020-08-13
Mapping to exposure classes
Regulation (EU) No 575/2013 (CRR) · Art. 112
Submitted 2020-07-25
Definition of qualifying holding according to Article 4 (1) 36 CRR2
Regulation (EU) No 575/2013 (CRR) · Art. 4
Submitted 2020-06-05
Treatment of non-withdrawable central bank reserves on C 66.
Regulation (EU) No 575/2013 (CRR) · Art. Article 415
Submitted 2020-06-02
Implementation of this article for subsidiaries that do not belong to the same resolution group as the EU parent institution.
Regulation (EU) No 575/2013 (CRR) · Art. 72e
Submitted 2020-01-27
Treatment of unfunded default fund contributions.
Regulation (EU) No 575/2013 (CRR) · Art. Articel 429
Submitted 2020-01-06
Off balance sheet items in scope of the credit risk framework
Regulation (EU) No 575/2013 (CRR) · Art. 5
Submitted 2019-10-24
Eligibility of convertible instruments as financial collateral
Regulation (EU) No 575/2013 (CRR) · Art. 197
Submitted 2019-02-04
Treatment of CIUs in internal model for market risk – partial use
Regulation (EU) No 575/2013 (CRR) · Art. 350
Submitted 2018-11-20
Treatement of liquidity generated by the overnight maturity of Withdrawable Central Cank reserve in Counterbalancing Capacity panel of Template C66
Regulation (EU) No 575/2013 (CRR) · Art. 415
Submitted 2018-10-09
Supervisory Formula Method - calculation of parameters
Regulation (EU) No 575/2013 (CRR) · Art. 262
Submitted 2018-09-11
Template 2 EU LI2 EBA/GL/2016/11 (Main sources of differences between regulatory exposure amounts and carrying values in fin statements)
Regulation (EU) No 575/2013 (CRR) · Art. 111, 166
Submitted 2018-05-08
Risk weighted assets calculation under Article 119(2) of the CRR
Regulation (EU) No 575/2013 (CRR) · Art. 114, 119
Submitted 2018-03-08
Impact of a profit and loss transfer agreement under German company law on the eligibility of CET1 instruments for subsidiaries having full discretion on contributing common equity tier 1 capital as defined in Article 26 of the CRR
Regulation (EU) No 575/2013 (CRR) · Art. 28
Submitted 2018-01-22
Weighted average risk weight calculation of the securitised exposures for an unrated securitisation position in STD according to Article 253
Regulation (EU) No 575/2013 (CRR) · Art. 253
Submitted 2017-12-01
CAP for synthetic securitisations of originator institutions in STD based on Article 252
Regulation (EU) No 575/2013 (CRR) · Art. 252
Submitted 2017-12-01
Question refer to Guidelines on disclosures requirments under Part Eight of Regulation No 575/2013 template 11 EU CR1-A Credit quality of exposures by exposure class and instrument
Regulation (EU) No 575/2013 (CRR) · Art. Articles 431 - 455
Submitted 2017-08-21
Consideration of surplus collateral received in providing further credit risk mitigation
Regulation (EU) No 575/2013 (CRR) · Art. 298
Submitted 2017-05-24
Application of IRB floor
Regulation (EU) No 575/2013 (CRR) · Art. 500
Submitted 2017-03-17
Mark-to-Market Method: Add-on for sold options
Regulation (EU) No 575/2013 (CRR) · Art. 274
Submitted 2017-03-08
Treatment of central bank reserves in third countries
Regulation (EU) No 575/2013 (CRR) · Art. 416
Submitted 2016-12-13
Supervisory permission for reducing own funds if the institution repays share premium to its shareholders
Regulation (EU) No 575/2013 (CRR) · Art. 26(1)(b), 77
Submitted 2016-06-28
Clarification on the treatment of regular clearing positions of central counterparties (CCPs) in the leverage ratio exposure measure (provided CCPs are subject to leverage ratio regulation)
Regulation (EU) No 575/2013 (CRR) · Art. 429a
Submitted 2016-05-27
Treatment of exposures to non-EU equivalent investment firms, non-EU equivalent credit institutions and non-EU equivalent exchanges.
Regulation (EU) No 575/2013 (CRR) · Art. 107
Submitted 2016-05-19
Consideration of collateral in the potential future credit exposure
Regulation (EU) No 575/2013 (CRR) · Art. 298
Submitted 2016-05-16
Counterparty Credit Risk, Credit Default Swaps
Regulation (EU) No 575/2013 (CRR) · Art. 299
Submitted 2016-04-07
Source: EBA Single Rulebook Q&A, ESMA Q&A, EIOPA Q&A, ESA Joint Q&As. Updated weekly. Q&As are non-binding guidance.
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.